Change of Name

Recorded: 2016-04-08 Pages: 3

Assignor

GLYCART BIOTECHNOLGY AG

Executed: 2010-06-28

Assignee

ROCHE GLYCART AG

WAGISTRASSE 18, SCHLIEREN-ZÜRICH, CH-8952, SWITZERLAND

Covered Properties (2)

Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity

Patent: 9,321,843 →

Application: 14/665,191 →

Publication: US 2015/0274837

Antibody Glycosylation Variants Having Increased Antibody-Dependent Cellular Cytotoxicity

Patent: 9,631,023 →

Application: 15/080,020 →

Publication: US 2016/0272719

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.